S

Shandong Weigao Orthopaedic Device Co Ltd
SSE:688161

Watchlist Manager
Shandong Weigao Orthopaedic Device Co Ltd
SSE:688161
Watchlist
Price: 31.55 CNY 4.47% Market Closed
Market Cap: ¥12.6B

EV/OCF

29.7
Current
31%
Cheaper
vs 3-y average of 43.4

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
29.7
=
Enterprise Value
¥8.4B
/
Operating Cash Flow
¥315.7m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
29.7
=
Enterprise Value
¥8.4B
/
Operating Cash Flow
¥315.7m

Valuation Scenarios

Shandong Weigao Orthopaedic Device Co Ltd is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (43.4), the stock would be worth ¥46.02 (46% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-32%
Maximum Upside
+46%
Average Downside
0%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 29.7 ¥31.55
0%
3-Year Average 43.4 ¥46.02
+46%
5-Year Average 34.4 ¥36.5
+16%
Industry Average 20.3 ¥21.58
-32%
Country Average 20.8 ¥22.09
-30%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close

Market Distribution

In line with most companies in China
Percentile
61st
Based on 6 190 companies
61st percentile
29.7
Low
0 — 11.5
Typical Range
11.5 — 39.2
High
39.2 —
Distribution Statistics
China
Min 0
30th Percentile 11.5
Median 20.8
70th Percentile 39.2
Max 266 666.7

Shandong Weigao Orthopaedic Device Co Ltd
Glance View

Market Cap
12.6B CNY
Industry
Health Care

Nestled in the bustling economic landscape of China, Shandong Weigao Orthopaedic Device Co Ltd has carved a respected niche for itself in the realm of medical equipment. The company, founded as a subsidiary of the larger Weigao Group, specializes in the design, production, and distribution of orthopedic devices. Its journey starts with an unwavering commitment to incorporating advanced technology into healthcare solutions. Shandong Weigao has honed its focus on spinal, trauma, and joint-related products, ensuring that its offerings meet international standards and cater to both domestic and global markets. Operating within an industry where precision and reliability are paramount, the company has leveraged a well-established network to distribute its products to hospitals, clinics, and healthcare facilities, thus embedding its roots deeply within the healthcare infrastructure. This thriving enterprise makes money by delivering value through its diverse product portfolio tailored to meet the complex and varied needs of orthopedic treatments. Its revenue model is centered around a combination of direct sales, strategic partnerships, and long-term contracts with healthcare providers. By engaging in continuous research and development, Shandong Weigao not only expands its product lines but also enhances existing solutions, ensuring they remain cutting-edge. This emphasis on innovation has enabled the company to maintain a competitive edge in a rapidly evolving market, positioning itself as a leader in China’s orthopedic device industry. Through strategic market penetration and an adept understanding of regulatory landscapes, Shandong Weigao Orthopaedic Device Co Ltd not only sustains its growth but also contributes significantly to the advancements in orthopedic healthcare.

Intrinsic Value
28.25 CNY
Overvaluation 10%
Intrinsic Value
Price ¥31.55
S
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett